The amount of fibrinogen-positive platelets predicts the occurrence of in-stent restenosis

Atherosclerosis. 2008 Mar;197(1):190-6. doi: 10.1016/j.atherosclerosis.2007.03.020. Epub 2007 May 7.

Abstract

Aims: To determine the value of fibrinogen-positive platelet-analysis in predicting restenosis after stent implantation in acute myocardial infarction patients.

Methods and results: Our patient population comprised 50 patients who underwent intravascular ultrasound (IVUS) guided stent implantation for acute myocardial infarction. In all cases, IVUS confirmed a deep vessel wall injury due to a ruptured plaque within the culprit lesion. Flow cytometry quantified the amount of platelets with surface-bound fibrinogen and thrombospondin before and immediately after the intervention. After 5 months, IVUS was repeated to assess the long-term results. In-stent restenosis - defined as a percent diameter stenosis of >50% - was detected in 11 of 45 patients who attended follow-up angiography. The amount of fibrinogen-positive platelets was significantly higher among patients who subsequently developed in-stent restenosis (50.5+/-6.8% fibrinogen-positive platelets immediately after intervention) than among those who did not (39.7+/-12.3% fibrinogen-positive platelets, p<0.005). Receiver operating characteristic curve revealed a 40% cut-off for fibrinogen-positive platelets immediately after the intervention to predict restenosis (p<0.05, sensitivity: 90.9%, specificity: 47.1%).

Conclusion: The amount of fibrinogen-positive platelets immediately after stent implantation predicts the occurrence of in-stent restenosis, as confirmed by IVUS in acute myocardial infarction patients.

MeSH terms

  • Adult
  • Aged
  • Angioplasty, Balloon, Coronary*
  • Biomarkers / metabolism
  • Blood Platelets / metabolism*
  • Coronary Restenosis / diagnosis*
  • Coronary Restenosis / epidemiology
  • Coronary Restenosis / metabolism*
  • Female
  • Fibrinogen / metabolism*
  • Flow Cytometry
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / diagnostic imaging
  • Myocardial Infarction / epidemiology
  • Myocardial Infarction / therapy
  • Predictive Value of Tests
  • Risk Factors
  • Stents*
  • Thrombospondins / metabolism
  • Ultrasonography, Interventional

Substances

  • Biomarkers
  • Thrombospondins
  • Fibrinogen